KRTAP10-2 Inhibitors
KRTAP10-2 inhibitors represent a class of chemical compounds that selectively target and modulate the activity of the keratin-associated protein 10-2 (KRTAP10-2). KRTAP10-2 is one of the keratin-associated proteins (KAPs) that plays a significant role in the structural organization and mechanical properties of hair and other keratin-rich tissues. KAPs, including KRTAP10-2, interact with keratin filaments to form a stable matrix, contributing to the rigidity, flexibility, and resilience of these tissues. Inhibitors of KRTAP10-2 are designed to disrupt or regulate the interactions between this specific protein and keratin filaments, affecting the assembly and function of keratin structures. These inhibitors can act by binding to active sites on KRTAP10-2, altering its conformation, or preventing it from associating with keratin filaments.
The development and study of KRTAP10-2 inhibitors are valuable for understanding the structural biology of keratin networks and their role in maintaining the integrity of keratinized tissues. Investigating these inhibitors helps to elucidate the molecular interactions between KRTAP10-2 and other components of the keratin matrix. Furthermore, by modulating KRTAP10-2 activity, researchers can explore how changes in keratin structure impact the physical properties of tissues like hair, nails, and skin. This research provides a deeper insight into the role of keratin-associated proteins in the formation of these tissues, contributing to advancements in the field of molecular biology, biochemistry, and structural protein research.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone may suppress KRTAP10-2 gene expression by interacting with glucocorticoid response elements within its promoter region. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid could potentially downregulate KRTAP10-2 expression by altering histone acetylation states and thereby changing gene accessibility. | ||||||
Dutasteride | 164656-23-9 | sc-207600 | 10 mg | $167.00 | 2 | |
Dutasteride might decrease KRTAP10-2 expression by inhibiting the enzyme 5-alpha-reductase, reducing dihydrotestosterone levels that could be involved in the gene's expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate could reduce KRTAP10-2 expression by hindering the activation of NF-kB signaling, a pathway that may be involved in hair follicle gene expression. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Hydroxychloroquine may decrease KRTAP10-2 expression by altering lysosomal pH and potentially disrupting cellular processes that control gene expression. | ||||||
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $75.00 $120.00 | 8 | |
13-cis-Retinoic acid could downregulate KRTAP10-2 expression by promoting retinoid-dependent differentiation of keratinocytes, leading to changes in hair follicle structure. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone might decrease KRTAP10-2 expression by activating PPARγ, which could lead to altered expression of genes associated with the hair follicle cycle. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib could decrease KRTAP10-2 expression by inhibiting the ABL tyrosine kinase, and consequently disrupting downstream signaling that governs hair follicle gene expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate might reduce KRTAP10-2 expression by inhibiting dihydrofolate reductase, leading to a reduction in nucleotide synthesis and thus affecting the rate of gene transcription. | ||||||
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $55.00 $250.00 | 6 | |
Bexarotene has the potential to decrease KRTAP10-2 expression by activating retinoid X receptors, which could alter the transcriptional regulation of genes involved in keratinization. | ||||||